ArticleCancers2021

Preclinical Evaluation of Recombinant Human IL15 Protein Fused with Albumin Binding Domain on Anti-PD-L1 Immunotherapy Efficiency and Anti-Tumor Immunity in Colon Cancer and Melanoma.

Fei-Ting Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.